Browse the full insider trade history of Kalaris Therapeutics, Inc., a publicly traded company based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €97.2m. The latest transaction was disclosed on 22 May 2026 (Acquisition). Among the most active insiders: AKKARAJU SRINIVAS. The full history is accessible without an account.
10
Insider Decl.
0
Thresholds
€5m
2 ops.
Buy Volume
€7,541
1 ops.
Sell Volume
27Σ signal
Buys €5m€7,541 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.